Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Measuring treatment effect in acute stroke trials

Pooja Khatri, Joseph Broderick

    Stroke
    |August 5, 2006
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Using radiological brain health to predict recurrence after ischemic stroke and transient ischemic attack: A population-based study.

    Neurology open access·2026
    Same author

    Relation between Time from Onset to Randomization and Benefit Magnitude in Recent Clinical Trials of Thrombectomy for Patients with Large Ischemic Cores.

    Annals of Indian Academy of Neurology·2026
    Same author

    Robotic Gastrectomy and Delivery of Adjuvant Systemic Therapy in Locally Advanced Gastric Adenocarcinoma: An NCDB Propensity Score-Matched Analysis.

    Cancers·2026
    Same author

    Ten years of Central IRB review for an NIH-funded large clinical trial network by an academic IRB: The NIH StrokeNet experience.

    Journal of clinical and translational science·2026
    Same author

    Neurologist Compensation and Productivity From 2013 to 2023 in the United States.

    Neurology·2026
    Same author

    Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

    Lancet (London, England)·2026